Table 2.

Association between activin A and clinical and biochemical variables

Clinical and biochemical characteristics	Patients			P
	All N=310	Low <429.0 pg/mL	High >429.0 pg/mL
SBP, cm Hg	13.1±2.2	13.1±1.9	12.6±2.3	0.190
DBP, cm Hg	7.5±1.3	7.7±1.2	7.2±1.4	0.021
Heart rate, b/min	75.5±16.2	76.9±17.4	72.5±14.0	0.111
LVEF, %	49.5±14.7	46.0±16.3	51.0±13.0	0.298
Vessel involved, %	6.9	8.7	7.5	0.792
LMA	50.5	62.3	40.3	0.010
LCx	72.7	78.3	67.2	0.146
LAD	48.6	44.9	47.8	0.740
RCA
Stenosis, %
<50%	5.8	12.2	2.9	0.047
(50-70) %	27.2	31.7	14.7
>70%	67.0	56.1	82.4
Single vessel, %	43.5	31.9	50.7	0.025
Multivessel, %	56.5	68.1	49.3
Insulin use, %	37.5	40.0	42.1	0.364
Statins, %	62.6	68.2	79.2	0.379
β Blokers, %	45.5	60.0	33.3	0.077
CEI, %	69.2	71.4	79.2	0.547
Aspirin, %	68.1	54.5	69.2	0.295
Furosemid, %	19.1	9.1	30.4	0.074
Glucose, mmol/L	9.8±5.6	8.4±4.8	8.6±4.2	0.762
Urea, mmol/L	6.3±3.3	5.8±3.7	6.0±2.4	0.650
Creatinin, µmol/L	93.7±28.9	88.9±24.3	86.7±25.9	0.594
Uric acid, µmol/L	337.4±125.3	263.3±111.1	296.3±96.2	0.206
TC, mmol/L	4.3±1.4	4.2±1.4	4.5±1.4	0.160
TG, mmol/L	1.4(0.3-12.1)	1.3(0.3-4.0)	1.4(0.5-12.1)	0.280
HDL-c, mmol/L	1.0±0.7	0.9±0.3	0.9±0.4	0.844
LDL-c, mmol/L	1.7±1.3	2.6±1.1	2.8±1.2	0.384
Lp (a), mg/L	107.0(14.5-1230.0)	108.0(14.5-780.0)	103.5(23.0-230.0)	0.409
ApoA1, g/L	1.0±0.3	0.9±0.2	1.0±0.3	0.846
ApoB, g/L	0.8±0.3	0.7±0.3	0.8±0.3	0.711
Hs-CRP, mg/L	5.0(0.2-1020.0)	6.1(0.2-1020)	5.0(0.2-500.0)	0.770
IL-6, pg/mL	8.2(1.5-3640.0)	8.5(2.2-3640.0)	8.1(1.5-855.4)	0.241

ApoA-1-apolipoprotein A-1, ApoB-apolipoprotein B, CEI-conversion enzyme inhibitor, DBP-diastolic blood pressure, HDL-c-high density lipoprotein cholesterol, hs-CRP-high sensitivity C-reactive protein, IL-6-Interleukin 6, LAD-left anterior descending, LCx-left circumflex, LDL-c-low density lipoprotein cholesterol, LMCA-left main coronary artery, Lp(a)-lipoprotein(a), LVEF-left ventricular ejection fraction, RCA-right coronary artery, SBP-systolic blood pressure, TC-total cholesterol, TG-triglyceride. Values are expressed as the mean±SD. P<0.05